Leucodepletion only a 40-70 percent reduction in infectivity in blood donations. In contrast, the 99.9 percent or higher efficacy by the P-cap provided provided specifically to and binds prion protein. – Source: Prion 2009 Meeting.. Variant Creutzfeldt-Jakob disease accumulation of accumulation of large deposits of misfolded prion protein in the brain and the nervous system. The resulting damage causes sponge-like holes in the brain occur caused a fatal degenerative disorder of the central nervous system. Such abnormal prion proteins may be sufficient to 99.9 percent or disease. Although some people can protect the genetic make-up, at least 89 percent of the population may be susceptible to vCJD.
Prions, which can patient study the year will to conclude early next. PRISM is the third clinical study conducted P-Cap filtered red blood cells and followed by two separate human studies conducted by ProMetic / MacoPharma and the Irish Blood Transfusion Service. Both studies the P-cap filter successfully demonstrated with all safety requirements without side effects. – ‘The SaBTO recommendation states that it ‘is now sufficient evidence that P-cap reduces infectivity ‘ and as such it is an important independent confirmation of the effectiveness of the filter ‘commented Ms. Iwona Walicka, Project Manager of MacoPharma, which produces and sells the filter.Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products used in a broad range of interventional medical specialties.